Novartis AG
METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

Abstract:

The disclosure provides methods of making CAR-expressing immune effector cells (e.g., T cells, or NK cells), and compositions and reaction mixtures comprising the same. The disclosure further provides methods of using said CAR-expressing immune effector cells.